Clinical Trials in Philadelphia

Showing 14421-14440 of 20,020 trials

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

NCT01009437

RATIONALE: Ritonavir may stop the growth of tumor cells by blocking some of the enzymes needed for cancer cell growth. Studying samples of blood and tissue from patients with breast cancer in the laboratory may help doctors learn more about the effects of ritonavir on biomarkers involved in breast cancer growth. PURPOSE: This phase I/II trial is studying the best dose of ritonavir and its effects on biomarkers in women undergoing surgery for newly diagnosed breast cancer.

Breast Cancer

Masonic Cancer Center, University of Minnesota28 participantsStarted May 2010

Minneapolis, Minnesota, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

NCT01687712

The purpose of this study is to show that AFOLIA, a recombinant manufactured human follicle stimulating hormone (r-hFSH) has a similar efficacy and safety profile compared to Gonal-f® RFF.

Infertility

Fertility Biotech AG1,100 participantsStarted Nov 2013

Tempe, Arizona, United States • Encino, California, United States • Newark, Delaware, United States +19 more locations

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

Find Trials by Condition in Philadelphia

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

The Study of AZD8529 for Smoking Cessation in Female Smokers

HIV/STI Prevention Among Black Adolescents With Mental Illnesses (Project GOLD)

Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)

AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture

A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis

Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma

RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer